Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

被引:1
|
作者
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ,4 ]
Mukherjee, Sudipto [5 ]
Bell, Kimberly [6 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构
[1] Cleveland Clin, Canc Biostatist, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Dept Translat Hematol & Oncol Res, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
[6] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH USA
关键词
D O I
10.1182/blood-2019-129096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
381
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Clinical impact of genetic features in Acute Myeloid Leukemia (AML)
    Doehner, K.
    Gaidzik, V., I
    Paschka, P.
    Schlenk, R. F.
    Doehner, H.
    ONKOLOGIE, 2012, 35 : 155 - 155
  • [32] Clinical relevance of telomerase activity in acute myeloid leukemia (AML).
    Gruber, A
    Xu, DW
    Peterson, C
    Pisa, P
    BLOOD, 1997, 90 (10) : 304 - 304
  • [33] Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer
    Jan, Jenny
    Osho, Azeez
    Murphy, Caitlin C.
    Mazure, Carolyn M.
    Singal, Amit G.
    Rich, Nicole E.
    GASTROENTEROLOGY, 2022, 163 (01) : 14 - +
  • [34] Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children's Oncology Group
    Rao, Pooja
    Li, Yimei
    Alonzo, Todd A.
    Sung, Lillian
    Gerbing, Robert B.
    Getz, Kelly D.
    Seif, Alix E.
    Miller, Tamara P.
    Huang, Yuan-Shung
    Bagatell, Rochelle
    Hall, Matthew
    Fisher, Brian T.
    Gamis, Alan S.
    Aplenc, Richard
    BLOOD, 2014, 124 (21)
  • [35] A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy
    Alibhai, Shabbir M. H.
    O'Neill, Sara
    Fisher-Schlombs, Karla
    Breunis, Henriette
    Brandwein, Joseph M.
    Timilshina, Narhari
    Tomlinson, George A.
    Klepin, Heidi D.
    Culos-Reed, S. Nicole
    LEUKEMIA RESEARCH, 2012, 36 (10) : 1255 - 1261
  • [36] Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada
    Alexander, Thomas B.
    Bhakta, Nickhill
    Kolb, E. Anders
    Rubnitz, Jeffrey E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [37] Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
    Muffly, Lori
    Yin, Jun
    Jacobson, Sawyer
    Wall, Anna
    Quiroz, Elisa
    Advani, Anjali S.
    Luger, Selina M.
    Tallman, Martin S.
    Litzow, Mark R.
    Foster, Matthew C.
    Erba, Harry P.
    Appelbaum, Frederick R.
    Larson, Richard A.
    Keegan, Theresa H. M.
    Stock, Wendy
    BLOOD ADVANCES, 2022, 6 (14) : 4085 - 4092
  • [38] Clozapine treatment associated with increased risk of acute myeloid leukemia (AML)
    Nielsen, Jimmi
    Boysen, Anders
    SCHIZOPHRENIA RESEARCH, 2010, 123 (2-3) : 270 - 272
  • [39] Clinical and cytogenetic responses to amonafide in secondary acute myeloid leukemia (AML).
    Allen, S. L.
    Kolitz, J. E.
    Lundberg, A. S.
    Capizzi, R. L.
    Budman, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 357S - 357S
  • [40] Gingival hyperplasia as first clinical sign of acute myeloid leukemia (AML)
    Ghidini, Giulia
    Meleti, Marco
    Vescovi, Paolo
    Manfredi, Maddalena
    DENTAL CADMOS, 2023, 91 (08) : 676 - 679